MedTrace Logo

IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease)

NCT05128357 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-11-22

No results posted yet for this study

Summary

Behçet's disease (BD) is an autoimmune, rare, and severe multisystemic inflammatory disease characterized by recurrent oral aphthous ulcers, genital ulcers, skin lesions, and both anterior and posterior uveitis; articular, vascular, gastroenteric and neurological involvement may also occur. The multi-organ involvement and the wide range of clinical spectrum make the diagnosis of BD challenging. Adherence has been defined as the "extent to which a person's behavior (in terms of taking medications, following diets, or executing other lifestyle changes) corresponds with agreed recommendations from a health care provider". The lack of medication adherence leads to poorer health outcomes for the patients, which affect quality of life, generate economic loss for the healthcare system and trigger uncertainty for the healthcare prescribers in dealing with the disease treatment. This challenge is particularly important in BD. The present study is therefore aimed at exploring the main reasons for low- or non-adherence to treatments in BD and to create a specific tool able to catch and monitor the reasons for low- or non-adherence in BD over time.

Objectives

* to explore the unmet needs in treatment adherence
* to create a toll aimed at identifying and monitoring the reasons of low treatment adherence
* to plan specific actions aimed at improving treatment adherence in BD

Conditions

  • Behçet Disease

Interventions

OTHER

the study is observational, no intervention foreseen

the study does not foresees any intervention, since it is a multi step observational study.

Sponsors & Collaborators

  • Azienda Ospedaliero, Universitaria Pisana

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-16
Primary Completion
2022-07-31
Completion
2022-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05128357 on ClinicalTrials.gov